ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04022	cGMP-PKG signaling pathway	12/201	167/8135	0.0008548	0.2222	0.2195	CALM1/ATP2B4/PLN/SLC25A6/ATP1B3/PPP1CA/GTF2IRD1/CNGB1/ADCY2/SLC25A5/EDNRB/PPP1CB	12
KEGG	hsa05168	Herpes simplex virus 1 infection	22/201	495/8135	0.005216	0.4588	0.4532	ZNF599/ZNF81/ZNF417/ZNF43/ZNF786/ZNF85/HLA-DQB1/HLA-DOA/PPP1CA/ZNF324/ZNF222/CYCS/BST2/ZNF641/ZNF268/IRAK1/ZNF749/ZNF10/ZNF746/ZNF836/PPP1CB/ZNF597	22
KEGG	hsa04744	Phototransduction	4/201	29/8135	0.005293	0.4588	0.4532	CALM1/GUCA1B/RHO/CNGB1	4
KEGG	hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	3/201	20/8135	0.01242	0.6057	0.5983	CHSY1/CSGALNACT2/XYLT1	3
KEGG	hsa00513	Various types of N-glycan biosynthesis	4/201	39/8135	0.01514	0.6057	0.5983	RPN2/MGAT4A/B4GALNT3/RPN1	4
KEGG	hsa05016	Huntington disease	14/201	306/8135	0.01925	0.6057	0.5983	PSMC2/PSMD13/CLTB/SLC25A6/PSMB6/PSMD3/SDHB/AP2S1/SLC25A5/CYCS/TFAM/TUBB2A/BDNF/CREBBP	14
KEGG	hsa03250	Viral life cycle - HIV-1	5/201	63/8135	0.01934	0.6057	0.5983	FEZ1/BST2/SUPT5H/CHMP4B/CREBBP	5
KEGG	hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/201	24/8135	0.02053	0.6057	0.5983	NDST1/XYLT1/HS3ST5	3
KEGG	hsa04024	cAMP signaling pathway	11/201	221/8135	0.02097	0.6057	0.5983	CALM1/ATP2B4/PLN/ATP1B3/PPP1CA/CNGB1/ADCY2/GPHA2/BDNF/PPP1CB/CREBBP	11
KEGG	hsa01200	Carbon metabolism	7/201	115/8135	0.02355	0.6124	0.605	PRPS1L1/SDHB/SHMT1/HK2/PGK1/ACSS1/TKTL1	7
KEGG	hsa03050	Proteasome	4/201	46/8135	0.0263	0.6217	0.6142	PSMC2/PSMD13/PSMB6/PSMD3	4
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	8/201	150/8135	0.03223	0.6983	0.6899	CALM1/ATP2B4/PLN/ATP1B3/PPP1CA/PPP2R5E/ADCY2/PPP1CB	8
KEGG	hsa04218	Cellular senescence	8/201	156/8135	0.03929	0.7483	0.7392	CALM1/ZFP36L1/RAD9B/SLC25A6/PPP1CA/PPID/SLC25A5/PPP1CB	8
KEGG	hsa04961	Endocrine and other factor-regulated calcium reabsorption	4/201	53/8135	0.04137	0.7483	0.7392	ATP2B4/CLTB/ATP1B3/AP2S1	4
KEGG	hsa04217	Necroptosis	8/201	159/8135	0.04317	0.7483	0.7392	SLC25A6/PPID/CHMP7/TNFAIP3/SLC25A5/TNFRSF10B/CHMP4B/SPATA2	8
KEGG	hsa00051	Fructose and mannose metabolism	3/201	33/8135	0.04711	0.7537	0.7445	PFKFB1/SORD/HK2	3
KEGG	hsa05145	Toxoplasmosis	6/201	112/8135	0.05862	0.7537	0.7445	HLA-DQB1/HLA-DOA/LAMC3/CYCS/IRAK1/LAMC1	6
KEGG	hsa05416	Viral myocarditis	4/201	60/8135	0.06042	0.7537	0.7445	PRF1/HLA-DQB1/HLA-DOA/CYCS	4
KEGG	hsa05169	Epstein-Barr virus infection	9/201	202/8135	0.06264	0.7537	0.7445	PSMC2/PSMD13/HLA-DQB1/HLA-DOA/PSMD3/TNFAIP3/CYCS/ISG15/IRAK1	9
KEGG	hsa00561	Glycerolipid metabolism	4/201	61/8135	0.06347	0.7537	0.7445	GPAT2/AGPAT1/DGKK/MBOAT1	4
KEGG	hsa05017	Spinocerebellar ataxia	7/201	143/8135	0.06374	0.7537	0.7445	PSMC2/PSMD13/SLC25A6/PSMB6/PSMD3/SLC25A5/CYCS	7
KEGG	hsa00120	Primary bile acid biosynthesis	2/201	17/8135	0.06479	0.7537	0.7445	ACOT8/AKR1C4	2
KEGG	hsa05330	Allograft rejection	3/201	38/8135	0.06667	0.7537	0.7445	PRF1/HLA-DQB1/HLA-DOA	3
KEGG	hsa04720	Long-term potentiation	4/201	67/8135	0.08338	0.8602	0.8498	CALM1/PPP1CA/PPP1CB/CREBBP	4
KEGG	hsa05332	Graft-versus-host disease	3/201	42/8135	0.08457	0.8602	0.8498	PRF1/HLA-DQB1/HLA-DOA	3
KEGG	hsa00670	One carbon pool by folate	2/201	20/8135	0.08629	0.8602	0.8498	ALDH1L2/SHMT1	2
KEGG	hsa04940	Type I diabetes mellitus	3/201	43/8135	0.08933	0.8602	0.8498	PRF1/HLA-DQB1/HLA-DOA	3
KEGG	hsa04916	Melanogenesis	5/201	101/8135	0.1044	0.8648	0.8543	CALM1/ADCY2/EDNRB/WNT5B/CREBBP	5
KEGG	hsa00562	Inositol phosphate metabolism	4/201	73/8135	0.106	0.8648	0.8543	INPP5E/INPP4A/PLCH2/ISYNA1	4
KEGG	hsa04964	Proximal tubule bicarbonate reclamation	2/201	23/8135	0.1096	0.8648	0.8543	ATP1B3/GLS2	2
KEGG	hsa01230	Biosynthesis of amino acids	4/201	75/8135	0.1141	0.8648	0.8543	PRPS1L1/SHMT1/PGK1/TKTL1	4
KEGG	hsa04971	Gastric acid secretion	4/201	76/8135	0.1182	0.8648	0.8543	CALM1/ATP1B3/KCNK2/ADCY2	4
KEGG	hsa04210	Apoptosis	6/201	136/8135	0.1202	0.8648	0.8543	PRF1/CTSZ/CTSL/DIABLO/CYCS/TNFRSF10B	6
KEGG	hsa05012	Parkinson disease	10/201	266/8135	0.1226	0.8648	0.8543	PSMC2/CALM1/PSMD13/SLC25A6/PSMB6/PSMD3/SDHB/SLC25A5/CYCS/TUBB2A	10
KEGG	hsa04922	Glucagon signaling pathway	5/201	107/8135	0.125	0.8648	0.8543	CALM1/PRKAA1/PFKFB1/ADCY2/CREBBP	5
KEGG	hsa00510	N-Glycan biosynthesis	3/201	50/8135	0.1256	0.8648	0.8543	RPN2/MGAT4A/RPN1	3
KEGG	hsa04979	Cholesterol metabolism	3/201	50/8135	0.1256	0.8648	0.8543	STARD3/NPC2/MYLIP	3
KEGG	hsa04371	Apelin signaling pathway	6/201	139/8135	0.1295	0.8648	0.8543	HDAC4/CALM1/PRKAA1/ADCY2/HDAC5/TFAM	6
KEGG	hsa05164	Influenza A	7/201	171/8135	0.1306	0.8648	0.8543	SLC25A6/HLA-DQB1/HLA-DOA/SLC25A5/CYCS/TNFRSF10B/CREBBP	7
KEGG	hsa04140	Autophagy - animal	6/201	141/8135	0.136	0.8648	0.8543	PRKAA1/AKT1S1/CTSL/RRAGB/RAB8A/RAB39B	6
KEGG	hsa05020	Prion disease	10/201	273/8135	0.1383	0.8648	0.8543	PSMC2/PSMD13/SLC25A6/PSMB6/PSMD3/SDHB/SLC25A5/CYCS/LAMC1/TUBB2A	10
KEGG	hsa05320	Autoimmune thyroid disease	3/201	53/8135	0.1425	0.8648	0.8543	PRF1/HLA-DQB1/HLA-DOA	3
KEGG	hsa05152	Tuberculosis	7/201	180/8135	0.1576	0.8648	0.8543	CALM1/HLA-DQB1/HLA-DOA/ITGAX/CYCS/IRAK1/CREBBP	7
KEGG	hsa05132	Salmonella infection	9/201	249/8135	0.1632	0.8648	0.8543	CASP5/EXOC4/NCKAP1L/CYCS/TNFRSF10B/S100A10/IRAK1/PFN1/TUBB2A	9
KEGG	hsa04144	Endocytosis	9/201	251/8135	0.1686	0.8648	0.8543	SNF8/ARF5/CLTB/AP2S1/CHMP7/VPS37D/EHD4/RAB8A/CHMP4B	9
KEGG	hsa00030	Pentose phosphate pathway	2/201	30/8135	0.1689	0.8648	0.8543	PRPS1L1/TKTL1	2
KEGG	hsa00630	Glyoxylate and dicarboxylate metabolism	2/201	30/8135	0.1689	0.8648	0.8543	SHMT1/ACSS1	2
KEGG	hsa01523	Antifolate resistance	2/201	30/8135	0.1689	0.8648	0.8543	FPGS/SHMT1	2
KEGG	hsa04512	ECM-receptor interaction	4/201	88/8135	0.1727	0.8648	0.8543	LAMC3/COL2A1/LAMC1/COL9A3	4
KEGG	hsa04152	AMPK signaling pathway	5/201	120/8135	0.1754	0.8648	0.8543	PRKAA1/AKT1S1/PFKFB1/PPP2R5E/RAB8A	5
KEGG	hsa05310	Asthma	2/201	31/8135	0.1778	0.8648	0.8543	HLA-DQB1/HLA-DOA	2
KEGG	hsa00640	Propanoate metabolism	2/201	32/8135	0.1867	0.8648	0.8543	ACSS1/DBT	2
KEGG	hsa04215	Apoptosis - multiple species	2/201	32/8135	0.1867	0.8648	0.8543	DIABLO/CYCS	2
KEGG	hsa04213	Longevity regulating pathway - multiple species	3/201	62/8135	0.1972	0.8648	0.8543	PRKAA1/AKT1S1/ADCY2	3
KEGG	hsa04970	Salivary secretion	4/201	93/8135	0.1975	0.8648	0.8543	CALM1/ATP2B4/ATP1B3/ADCY2	4
KEGG	hsa05323	Rheumatoid arthritis	4/201	93/8135	0.1975	0.8648	0.8543	LTB/HLA-DQB1/HLA-DOA/CTSL	4
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	15/201	476/8135	0.1983	0.8648	0.8543	PSMC2/CALM1/PSMD13/SLC25A6/PSMB6/PPID/PSMD3/SDHB/SLC25A5/CYCS/RAB8A/TUBB2A/WNT5B/BDNF/RAB39B	15
KEGG	hsa00040	Pentose and glucuronate interconversions	2/201	34/8135	0.2048	0.8648	0.8543	DHDH/SORD	2
KEGG	hsa04927	Cortisol synthesis and secretion	3/201	65/8135	0.2165	0.8648	0.8543	KCNK2/ADCY2/KCNA4	3
KEGG	hsa03015	mRNA surveillance pathway	4/201	97/8135	0.2182	0.8648	0.8543	PPP1CA/PPP2R5E/NCBP1/PPP1CB	4
KEGG	hsa04070	Phosphatidylinositol signaling system	4/201	97/8135	0.2182	0.8648	0.8543	CALM1/INPP5E/INPP4A/DGKK	4
KEGG	hsa00350	Tyrosine metabolism	2/201	36/8135	0.223	0.8648	0.8543	GSTZ1/AOC3	2
KEGG	hsa00760	Nicotinate and nicotinamide metabolism	2/201	36/8135	0.223	0.8648	0.8543	SIRT6/NADK2	2
KEGG	hsa04114	Oocyte meiosis	5/201	131/8135	0.2231	0.8648	0.8543	CALM1/PPP1CA/PPP2R5E/ADCY2/PPP1CB	5
KEGG	hsa00564	Glycerophospholipid metabolism	4/201	98/8135	0.2234	0.8648	0.8543	GPAT2/AGPAT1/DGKK/MBOAT1	4
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	4/201	98/8135	0.2234	0.8648	0.8543	CALM1/PPP1CA/ADCY2/PPP1CB	4
KEGG	hsa04925	Aldosterone synthesis and secretion	4/201	98/8135	0.2234	0.8648	0.8543	CALM1/ATP2B4/ATP1B3/ADCY2	4
KEGG	hsa04142	Lysosome	5/201	132/8135	0.2276	0.8648	0.8543	CLTB/CTSZ/CTSL/NPC2/AP3B1	5
KEGG	hsa00010	Glycolysis / Gluconeogenesis	3/201	67/8135	0.2295	0.8648	0.8543	HK2/PGK1/ACSS1	3
KEGG	hsa05010	Alzheimer disease	12/201	384/8135	0.2406	0.8804	0.8697	PSMC2/CALM1/PSMD13/SLC25A6/PSMB6/PPID/PSMD3/SDHB/SLC25A5/CYCS/TUBB2A/WNT5B	12
KEGG	hsa05031	Amphetamine addiction	3/201	69/8135	0.2427	0.8804	0.8697	CALM1/PPP1CA/PPP1CB	3
KEGG	hsa04972	Pancreatic secretion	4/201	102/8135	0.2448	0.8804	0.8697	ATP2B4/ATP1B3/ADCY2/RAB8A	4
KEGG	hsa05230	Central carbon metabolism in cancer	3/201	70/8135	0.2493	0.8804	0.8697	SIRT6/HK2/GLS2	3
KEGG	hsa04910	Insulin signaling pathway	5/201	137/8135	0.2506	0.8804	0.8697	CALM1/PRKAA1/PPP1CA/HK2/PPP1CB	5
KEGG	hsa00260	Glycine, serine and threonine metabolism	2/201	40/8135	0.2598	0.9008	0.8898	AOC3/SHMT1	2
KEGG	hsa03440	Homologous recombination	2/201	41/8135	0.2691	0.9097	0.8987	RAD51B/BABAM1	2
KEGG	hsa04115	p53 signaling pathway	3/201	73/8135	0.2694	0.9097	0.8987	RPRM/CYCS/TNFRSF10B	3
KEGG	hsa05014	Amyotrophic lateral sclerosis	11/201	364/8135	0.2889	0.963	0.9513	PSMC2/PSMD13/PSMB6/PSMD3/SDHB/NCBP1/CYCS/RAB8A/PFN1/TUBB2A/RAB39B	11
KEGG	hsa05140	Leishmaniasis	3/201	77/8135	0.2965	0.9676	0.9558	HLA-DQB1/HLA-DOA/IRAK1	3
KEGG	hsa04612	Antigen processing and presentation	3/201	78/8135	0.3032	0.9676	0.9558	HLA-DQB1/HLA-DOA/CTSL	3
KEGG	hsa03022	Basal transcription factors	2/201	45/8135	0.3059	0.9676	0.9558	GTF2IRD1/TAF13	2
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	7/201	222/8135	0.3094	0.9676	0.9558	SLC25A6/HLA-DQB1/HLA-DOA/ADCY2/SLC25A5/RANBP1/CREBBP	7
KEGG	hsa00603	Glycosphingolipid biosynthesis - globo and isoglobo series	1/201	15/8135	0.3131	0.9676	0.9558	FUT2	1
KEGG	hsa05034	Alcoholism	6/201	187/8135	0.3161	0.9676	0.9558	HDAC4/CALM1/PPP1CA/HDAC5/BDNF/PPP1CB	6
KEGG	hsa04145	Phagosome	5/201	152/8135	0.3224	0.9676	0.9558	HLA-DQB1/HLA-DOA/CTSL/FCAR/TUBB2A	5
KEGG	hsa04973	Carbohydrate digestion and absorption	2/201	47/8135	0.3242	0.9676	0.9558	ATP1B3/HK2	2
KEGG	hsa00360	Phenylalanine metabolism	1/201	16/8135	0.3301	0.9676	0.9558	AOC3	1
KEGG	hsa04921	Oxytocin signaling pathway	5/201	154/8135	0.3322	0.9676	0.9558	CALM1/PRKAA1/PPP1CA/ADCY2/PPP1CB	5
KEGG	hsa04934	Cushing syndrome	5/201	155/8135	0.3371	0.9676	0.9558	WDR5/KCNK2/ADCY2/KCNA4/WNT5B	5
KEGG	hsa04722	Neurotrophin signaling pathway	4/201	119/8135	0.3391	0.9676	0.9558	CALM1/IRAK1/ZNF274/BDNF	4
KEGG	hsa04150	mTOR signaling pathway	5/201	156/8135	0.3421	0.9676	0.9558	PRKAA1/AKT1S1/RRAGB/LAMTOR4/WNT5B	5
KEGG	hsa04672	Intestinal immune network for IgA production	2/201	49/8135	0.3424	0.9676	0.9558	HLA-DQB1/HLA-DOA	2
KEGG	hsa04611	Platelet activation	4/201	124/8135	0.3673	0.9832	0.9712	PPP1CA/SNAP23/ADCY2/PPP1CB	4
KEGG	hsa04510	Focal adhesion	6/201	201/8135	0.3779	0.9832	0.9712	PPP1CA/LAMC3/COL2A1/LAMC1/PPP1CB/COL9A3	6
KEGG	hsa04211	Longevity regulating pathway	3/201	89/8135	0.3779	0.9832	0.9712	PRKAA1/AKT1S1/ADCY2	3
KEGG	hsa04727	GABAergic synapse	3/201	89/8135	0.3779	0.9832	0.9712	GABRR3/ADCY2/GLS2	3
KEGG	hsa04976	Bile secretion	3/201	89/8135	0.3779	0.9832	0.9712	ATP1B3/ADCY2/ABCB1	3
KEGG	hsa04151	PI3K-Akt signaling pathway	10/201	354/8135	0.378	0.9832	0.9712	PRKAA1/LPAR3/LAMC3/PPP2R5E/PKN3/EFNA5/COL2A1/LAMC1/BDNF/COL9A3	10
KEGG	hsa04020	Calcium signaling pathway	7/201	240/8135	0.3821	0.9832	0.9712	CALM1/ATP2B4/PLN/SLC25A6/ADCY2/SLC25A5/EDNRB	7
KEGG	hsa05415	Diabetic cardiomyopathy	6/201	203/8135	0.3868	0.9832	0.9712	PLN/SLC25A6/PPP1CA/SDHB/SLC25A5/PPP1CB	6
KEGG	hsa00100	Steroid biosynthesis	1/201	20/8135	0.3941	0.9832	0.9712	FDFT1	1
KEGG	hsa05222	Small cell lung cancer	3/201	92/8135	0.3981	0.9832	0.9712	LAMC3/CYCS/LAMC1	3
KEGG	hsa04728	Dopaminergic synapse	4/201	132/8135	0.4123	0.9832	0.9712	CALM1/PPP1CA/PPP2R5E/PPP1CB	4
KEGG	hsa04015	Rap1 signaling pathway	6/201	210/8135	0.4179	0.9832	0.9712	CALM1/LPAR3/ADCY2/EVL/EFNA5/PFN1	6
KEGG	hsa04270	Vascular smooth muscle contraction	4/201	134/8135	0.4234	0.9832	0.9712	CALM1/PPP1CA/ADCY2/PPP1CB	4
KEGG	hsa00220	Arginine biosynthesis	1/201	22/8135	0.4237	0.9832	0.9712	GLS2	1
KEGG	hsa05150	Staphylococcus aureus infection	3/201	96/8135	0.4247	0.9832	0.9712	HLA-DQB1/HLA-DOA/FCAR	3
KEGG	hsa04330	Notch signaling pathway	2/201	59/8135	0.4304	0.9832	0.9712	DTX4/CREBBP	2
KEGG	hsa04713	Circadian entrainment	3/201	97/8135	0.4313	0.9832	0.9712	CALM1/NOS1AP/ADCY2	3
KEGG	hsa04978	Mineral absorption	2/201	60/8135	0.4389	0.9832	0.9712	ATP2B4/ATP1B3	2
KEGG	hsa00140	Steroid hormone biosynthesis	2/201	61/8135	0.4473	0.9832	0.9712	SRD5A1/AKR1C4	2
KEGG	hsa00590	Arachidonic acid metabolism	2/201	61/8135	0.4473	0.9832	0.9712	PTGDS/CYP4F8	2
KEGG	hsa05418	Fluid shear stress and atherosclerosis	4/201	139/8135	0.4511	0.9832	0.9712	CALM1/PRKAA1/CTSL/GSTM1	4
KEGG	hsa04810	Regulation of actin cytoskeleton	6/201	218/8135	0.4532	0.9832	0.9712	DIAPH2/PPP1CA/NCKAP1L/ITGAX/PFN1/PPP1CB	6
KEGG	hsa05146	Amoebiasis	3/201	102/8135	0.4638	0.9832	0.9712	LAMC3/SERPINB6/LAMC1	3
KEGG	hsa04974	Protein digestion and absorption	3/201	103/8135	0.4702	0.9832	0.9712	ATP1B3/COL2A1/COL9A3	3
KEGG	hsa04064	NF-kappa B signaling pathway	3/201	104/8135	0.4766	0.9832	0.9712	LTB/TNFAIP3/IRAK1	3
KEGG	hsa00790	Folate biosynthesis	1/201	26/8135	0.4787	0.9832	0.9712	FPGS	1
KEGG	hsa05321	Inflammatory bowel disease	2/201	65/8135	0.4802	0.9832	0.9712	HLA-DQB1/HLA-DOA	2
KEGG	hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1/201	27/8135	0.4917	0.9832	0.9712	FUT2	1
KEGG	hsa03040	Spliceosome	4/201	147/8135	0.4944	0.9832	0.9712	PRPF31/DHX8/NCBP1/TRA2A	4
KEGG	hsa04072	Phospholipase D signaling pathway	4/201	148/8135	0.4998	0.9832	0.9712	AGPAT1/LPAR3/DGKK/ADCY2	4
KEGG	hsa04931	Insulin resistance	3/201	108/8135	0.5018	0.9832	0.9712	PRKAA1/PPP1CA/PPP1CB	3
KEGG	hsa04514	Cell adhesion molecules	4/201	149/8135	0.5051	0.9832	0.9712	HLA-DQB1/HLA-DOA/VTCN1/PTPRM	4
KEGG	hsa04066	HIF-1 signaling pathway	3/201	109/8135	0.508	0.9832	0.9712	HK2/PGK1/CREBBP	3
KEGG	hsa04392	Hippo signaling pathway - multiple species	1/201	29/8135	0.5165	0.9832	0.9712	DCHS1	1
KEGG	hsa04520	Adherens junction	2/201	71/8135	0.5273	0.9832	0.9712	PTPRM/CREBBP	2
KEGG	hsa00020	Citrate cycle (TCA cycle)	1/201	30/8135	0.5285	0.9832	0.9712	SDHB	1
KEGG	hsa04724	Glutamatergic synapse	3/201	114/8135	0.5383	0.9832	0.9712	HOMER2/ADCY2/GLS2	3
KEGG	hsa05130	Pathogenic Escherichia coli infection	5/201	197/8135	0.5398	0.9832	0.9712	NCKAP1L/CYCS/TNFRSF10B/IRAK1/TUBB2A	5
KEGG	hsa00052	Galactose metabolism	1/201	31/8135	0.5402	0.9832	0.9712	HK2	1
KEGG	hsa00410	beta-Alanine metabolism	1/201	31/8135	0.5402	0.9832	0.9712	AOC3	1
KEGG	hsa04710	Circadian rhythm	1/201	31/8135	0.5402	0.9832	0.9712	PRKAA1	1
KEGG	hsa01524	Platinum drug resistance	2/201	73/8135	0.5423	0.9832	0.9712	CYCS/GSTM1	2
KEGG	hsa04918	Thyroid hormone synthesis	2/201	75/8135	0.557	0.9832	0.9712	ATP1B3/ADCY2	2
KEGG	hsa03410	Base excision repair	1/201	33/8135	0.5628	0.9832	0.9712	MUTYH	1
KEGG	hsa04130	SNARE interactions in vesicular transport	1/201	33/8135	0.5628	0.9832	0.9712	SNAP23	1
KEGG	hsa05133	Pertussis	2/201	76/8135	0.5642	0.9832	0.9712	CALM1/IRAK1	2
KEGG	hsa04935	Growth hormone synthesis, secretion and action	3/201	119/8135	0.5675	0.9832	0.9712	GHRHR/ADCY2/CREBBP	3
KEGG	hsa05205	Proteoglycans in cancer	5/201	205/8135	0.5755	0.9832	0.9712	PPP1CA/CTSL/TFAP4/WNT5B/PPP1CB	5
KEGG	hsa05131	Shigellosis	6/201	247/8135	0.5755	0.9832	0.9712	AKT1S1/PPID/HK2/RRAGB/CYCS/PFN1	6
KEGG	hsa05165	Human papillomavirus infection	8/201	331/8135	0.577	0.9832	0.9712	LAMC3/PPP2R5E/COL2A1/ISG15/LAMC1/WNT5B/CREBBP/COL9A3	8
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	2/201	78/8135	0.5784	0.9832	0.9712	DHDH/GSTM1	2
KEGG	hsa04721	Synaptic vesicle cycle	2/201	78/8135	0.5784	0.9832	0.9712	CLTB/AP2S1	2
KEGG	hsa04919	Thyroid hormone signaling pathway	3/201	121/8135	0.5789	0.9832	0.9712	PLN/ATP1B3/CREBBP	3
KEGG	hsa03018	RNA degradation	2/201	79/8135	0.5854	0.9832	0.9712	TOB1/EXOSC1	2
KEGG	hsa00500	Starch and sucrose metabolism	1/201	36/8135	0.5945	0.9832	0.9712	HK2	1
KEGG	hsa04310	Wnt signaling pathway	4/201	167/8135	0.5957	0.9832	0.9712	VANGL2/TBL1Y/WNT5B/CREBBP	4
KEGG	hsa00250	Alanine, aspartate and glutamate metabolism	1/201	37/8135	0.6046	0.9832	0.9712	GLS2	1
KEGG	hsa01250	Biosynthesis of nucleotide sugars	1/201	37/8135	0.6046	0.9832	0.9712	HK2	1
KEGG	hsa04960	Aldosterone-regulated sodium reabsorption	1/201	37/8135	0.6046	0.9832	0.9712	ATP1B3	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	4/201	171/8135	0.6144	0.9832	0.9712	RPN2/ERP29/EDEM2/RPN1	4
KEGG	hsa00230	Purine metabolism	3/201	128/8135	0.6173	0.9832	0.9712	PDE6D/PRPS1L1/ADCY2	3
KEGG	hsa04926	Relaxin signaling pathway	3/201	129/8135	0.6225	0.9832	0.9712	RLN1/ADCY2/EDNRB	3
KEGG	hsa04610	Complement and coagulation cascades	2/201	85/8135	0.6254	0.9832	0.9712	VSIG4/ITGAX	2
KEGG	hsa04911	Insulin secretion	2/201	86/8135	0.6318	0.9832	0.9712	ATP1B3/ADCY2	2
KEGG	hsa04068	FoxO signaling pathway	3/201	131/8135	0.6329	0.9832	0.9712	PRKAA1/HOMER2/CREBBP	3
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	3/201	131/8135	0.6329	0.9832	0.9712	PRF1/TNFRSF10B/RAET1E	3
KEGG	hsa05033	Nicotine addiction	1/201	40/8135	0.6333	0.9832	0.9712	GABRR3	1
KEGG	hsa04540	Gap junction	2/201	88/8135	0.6443	0.9832	0.9712	ADCY2/TUBB2A	2
KEGG	hsa04080	Neuroactive ligand-receptor interaction	8/201	353/8135	0.65	0.9832	0.9712	GHRHR/LPAR3/RLN1/TAC3/GABRR3/P2RY10/EDNRB/GPHA2	8
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	5/201	223/8135	0.6502	0.9832	0.9712	SLC25A6/SDHB/SLC25A5/AKR1C4/GSTM1	5
KEGG	hsa05206	MicroRNAs in cancer	7/201	310/8135	0.6503	0.9832	0.9712	HDAC4/TRIM71/EFNA5/HDAC5/GLS2/ABCB1/CREBBP	7
KEGG	hsa04975	Fat digestion and absorption	1/201	43/8135	0.6599	0.9832	0.9712	AGPAT1	1
KEGG	hsa05032	Morphine addiction	2/201	91/8135	0.6624	0.9832	0.9712	GABRR3/ADCY2	2
KEGG	hsa04915	Estrogen signaling pathway	3/201	138/8135	0.6678	0.9832	0.9712	CALM1/ADCY2/ESR2	3
KEGG	hsa04658	Th1 and Th2 cell differentiation	2/201	92/8135	0.6683	0.9832	0.9712	HLA-DQB1/HLA-DOA	2
KEGG	hsa05162	Measles	3/201	139/8135	0.6726	0.9832	0.9712	TNFAIP3/CYCS/IRAK1	3
KEGG	hsa04912	GnRH signaling pathway	2/201	93/8135	0.6741	0.9832	0.9712	CALM1/ADCY2	2
KEGG	hsa02010	ABC transporters	1/201	45/8135	0.6766	0.9832	0.9712	ABCB1	1
KEGG	hsa04714	Thermogenesis	5/201	232/8135	0.6843	0.9832	0.9712	PRKAA1/SIRT6/AKT1S1/SDHB/ADCY2	5
KEGG	hsa04930	Type II diabetes mellitus	1/201	46/8135	0.6847	0.9832	0.9712	HK2	1
KEGG	hsa04936	Alcoholic liver disease	3/201	142/8135	0.6866	0.9832	0.9712	PRKAA1/IRAK1/TRA2A	3
KEGG	hsa05414	Dilated cardiomyopathy	2/201	96/8135	0.691	0.9832	0.9712	PLN/ADCY2	2
KEGG	hsa00620	Pyruvate metabolism	1/201	47/8135	0.6925	0.9832	0.9712	ACSS1	1
KEGG	hsa04613	Neutrophil extracellular trap formation	4/201	190/8135	0.6959	0.9832	0.9712	HDAC4/SLC25A6/SLC25A5/HDAC5	4
KEGG	hsa00280	Valine, leucine and isoleucine degradation	1/201	48/8135	0.7001	0.9832	0.9712	DBT	1
KEGG	hsa01522	Endocrine resistance	2/201	98/8135	0.7018	0.9832	0.9712	ADCY2/ESR2	2
KEGG	hsa04640	Hematopoietic cell lineage	2/201	99/8135	0.7071	0.9832	0.9712	HLA-DQB1/HLA-DOA	2
KEGG	hsa00520	Amino sugar and nucleotide sugar metabolism	1/201	49/8135	0.7076	0.9832	0.9712	HK2	1
KEGG	hsa05030	Cocaine addiction	1/201	49/8135	0.7076	0.9832	0.9712	BDNF	1
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	2/201	100/8135	0.7124	0.9832	0.9712	ACKR4/TNFRSF10B	2
KEGG	hsa05110	Vibrio cholerae infection	1/201	50/8135	0.7149	0.9832	0.9712	KDELR1	1
KEGG	hsa00330	Arginine and proline metabolism	1/201	51/8135	0.7219	0.9832	0.9712	CKM	1
KEGG	hsa04913	Ovarian steroidogenesis	1/201	51/8135	0.7219	0.9832	0.9712	ADCY2	1
KEGG	hsa04620	Toll-like receptor signaling pathway	2/201	104/8135	0.7325	0.9832	0.9712	IRF5/IRAK1	2
KEGG	hsa01240	Biosynthesis of cofactors	3/201	153/8135	0.7343	0.9832	0.9712	FPGS/SHMT1/NADK2	3
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	2/201	106/8135	0.7421	0.9832	0.9712	ADCY2/MMP25	2
KEGG	hsa03460	Fanconi anemia pathway	1/201	54/8135	0.7422	0.9832	0.9712	FANCG	1
KEGG	hsa04932	Non-alcoholic fatty liver disease	3/201	155/8135	0.7423	0.9832	0.9712	PRKAA1/SDHB/CYCS	3
KEGG	hsa05203	Viral carcinogenesis	4/201	204/8135	0.7477	0.9832	0.9712	HDAC4/HDAC5/RANBP1/CREBBP	4
KEGG	hsa04390	Hippo signaling pathway	3/201	157/8135	0.7501	0.9832	0.9712	PPP1CA/WNT5B/PPP1CB	3
KEGG	hsa03013	Nucleocytoplasmic transport	2/201	108/8135	0.7515	0.9832	0.9712	AAAS/NCBP1	2
KEGG	hsa04659	Th17 cell differentiation	2/201	108/8135	0.7515	0.9832	0.9712	HLA-DQB1/HLA-DOA	2
KEGG	hsa04340	Hedgehog signaling pathway	1/201	56/8135	0.7548	0.9832	0.9712	HHATL	1
KEGG	hsa04923	Regulation of lipolysis in adipocytes	1/201	56/8135	0.7548	0.9832	0.9712	ADCY2	1
KEGG	hsa05134	Legionellosis	1/201	57/8135	0.7609	0.9832	0.9712	CYCS	1
KEGG	hsa00240	Pyrimidine metabolism	1/201	58/8135	0.7669	0.9832	0.9712	DCTD	1
KEGG	hsa00480	Glutathione metabolism	1/201	58/8135	0.7669	0.9832	0.9712	GSTM1	1
KEGG	hsa05161	Hepatitis B	3/201	162/8135	0.7689	0.9832	0.9712	CYCS/IRAK1/CREBBP	3
KEGG	hsa05170	Human immunodeficiency virus 1 infection	4/201	212/8135	0.7741	0.9832	0.9712	CALM1/CYCS/BST2/IRAK1	4
KEGG	hsa05417	Lipid and atherosclerosis	4/201	215/8135	0.7834	0.9832	0.9712	CALM1/CYCS/TNFRSF10B/IRAK1	4
KEGG	hsa05225	Hepatocellular carcinoma	3/201	168/8135	0.7899	0.9832	0.9712	PBRM1/WNT5B/GSTM1	3
KEGG	hsa00310	Lysine degradation	1/201	63/8135	0.7945	0.9832	0.9712	NSD1	1
KEGG	hsa04623	Cytosolic DNA-sensing pathway	1/201	63/8135	0.7945	0.9832	0.9712	AIM2	1
KEGG	hsa05217	Basal cell carcinoma	1/201	63/8135	0.7945	0.9832	0.9712	WNT5B	1
KEGG	hsa04071	Sphingolipid signaling pathway	2/201	119/8135	0.7977	0.9832	0.9712	PPP2R5E/NSMAF	2
KEGG	hsa04929	GnRH secretion	1/201	64/8135	0.7996	0.9832	0.9712	ESR2	1
KEGG	hsa00970	Aminoacyl-tRNA biosynthesis	1/201	66/8135	0.8095	0.9832	0.9712	RARS2	1
KEGG	hsa00830	Retinol metabolism	1/201	68/8135	0.8188	0.9832	0.9712	CYP27C1	1
KEGG	hsa04920	Adipocytokine signaling pathway	1/201	69/8135	0.8234	0.9832	0.9712	PRKAA1	1
KEGG	hsa04924	Renin secretion	1/201	69/8135	0.8234	0.9832	0.9712	CALM1	1
KEGG	hsa05204	Chemical carcinogenesis - DNA adducts	1/201	69/8135	0.8234	0.9832	0.9712	GSTM1	1
KEGG	hsa05211	Renal cell carcinoma	1/201	69/8135	0.8234	0.9832	0.9712	CREBBP	1
KEGG	hsa04622	RIG-I-like receptor signaling pathway	1/201	70/8135	0.8278	0.9832	0.9712	ISG15	1
KEGG	hsa04917	Prolactin signaling pathway	1/201	70/8135	0.8278	0.9832	0.9712	ESR2	1
KEGG	hsa00982	Drug metabolism - cytochrome P450	1/201	72/8135	0.8362	0.9832	0.9712	GSTM1	1
KEGG	hsa04621	NOD-like receptor signaling pathway	3/201	184/8135	0.8382	0.9832	0.9712	CASP5/AIM2/TNFAIP3	3
KEGG	hsa05214	Glioma	1/201	75/8135	0.8482	0.9832	0.9712	CALM1	1
KEGG	hsa00190	Oxidative phosphorylation	2/201	134/8135	0.8485	0.9832	0.9712	SDHB/CYCS	2
KEGG	hsa05322	Systemic lupus erythematosus	2/201	136/8135	0.8543	0.9832	0.9712	HLA-DQB1/HLA-DOA	2
KEGG	hsa05100	Bacterial invasion of epithelial cells	1/201	77/8135	0.8557	0.9832	0.9712	CLTB	1
KEGG	hsa04060	Cytokine-cytokine receptor interaction	5/201	295/8135	0.8599	0.9832	0.9712	LTB/TNFRSF11B/ACKR4/TNFRSF10B/IL36G	5
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	3/201	194/8135	0.8633	0.9832	0.9712	CALM1/CYCS/CREBBP	3
KEGG	hsa00983	Drug metabolism - other enzymes	1/201	80/8135	0.8662	0.9832	0.9712	GSTM1	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	2/201	142/8135	0.8706	0.9832	0.9712	RHOBTB1/RHOBTB2	2
KEGG	hsa04146	Peroxisome	1/201	82/8135	0.8728	0.9832	0.9712	ACOT8	1
KEGG	hsa01232	Nucleotide metabolism	1/201	85/8135	0.8821	0.9832	0.9712	DCTD	1
KEGG	hsa05224	Breast cancer	2/201	147/8135	0.8828	0.9832	0.9712	WNT5B/ESR2	2
KEGG	hsa05210	Colorectal cancer	1/201	86/8135	0.885	0.9832	0.9712	CYCS	1
KEGG	hsa04723	Retrograde endocannabinoid signaling	2/201	148/8135	0.8852	0.9832	0.9712	GABRR3/ADCY2	2
KEGG	hsa05226	Gastric cancer	2/201	149/8135	0.8874	0.9832	0.9712	ABCB1/WNT5B	2
KEGG	hsa04260	Cardiac muscle contraction	1/201	87/8135	0.8879	0.9832	0.9712	ATP1B3	1
KEGG	hsa05410	Hypertrophic cardiomyopathy	1/201	90/8135	0.8961	0.9832	0.9712	PRKAA1	1
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	3/201	212/8135	0.9	0.9832	0.9712	ADCY2/ESR2/GSTM1	3
KEGG	hsa04350	TGF-beta signaling pathway	1/201	94/8135	0.9061	0.9832	0.9712	CREBBP	1
KEGG	hsa04657	IL-17 signaling pathway	1/201	94/8135	0.9061	0.9832	0.9712	TNFAIP3	1
KEGG	hsa05215	Prostate cancer	1/201	97/8135	0.913	0.9832	0.9712	CREBBP	1
KEGG	hsa05231	Choline metabolism in cancer	1/201	98/8135	0.9151	0.9832	0.9712	DGKK	1
KEGG	hsa05163	Human cytomegalovirus infection	3/201	225/8135	0.9207	0.9832	0.9712	CALM1/ADCY2/CYCS	3
KEGG	hsa04914	Progesterone-mediated oocyte maturation	1/201	102/8135	0.9233	0.9832	0.9712	ADCY2	1
KEGG	hsa05142	Chagas disease	1/201	102/8135	0.9233	0.9832	0.9712	IRAK1	1
KEGG	hsa04530	Tight junction	2/201	169/8135	0.9251	0.9832	0.9712	PRKAA1/RAB8A	2
KEGG	hsa04625	C-type lectin receptor signaling pathway	1/201	104/8135	0.9271	0.9832	0.9712	CALM1	1
KEGG	hsa04014	Ras signaling pathway	3/201	232/8135	0.9302	0.9832	0.9712	CALM1/EFNA5/BDNF	3
KEGG	hsa05171	Coronavirus disease - COVID-19	3/201	232/8135	0.9302	0.9832	0.9712	ISG15/IRAK1/RPS29	3
KEGG	hsa04668	TNF signaling pathway	1/201	112/8135	0.9405	0.9845	0.9725	TNFAIP3	1
KEGG	hsa04725	Cholinergic synapse	1/201	113/8135	0.942	0.9845	0.9725	ADCY2	1
KEGG	hsa04360	Axon guidance	2/201	182/8135	0.9428	0.9845	0.9725	EFNA5/WNT5B	2
KEGG	hsa04110	Cell cycle	1/201	126/8135	0.9583	0.9948	0.9827	CREBBP	1
KEGG	hsa04380	Osteoclast differentiation	1/201	128/8135	0.9604	0.9948	0.9827	TNFRSF11B	1
KEGG	hsa05135	Yersinia infection	1/201	137/8135	0.9685	0.9948	0.9827	IRAK1	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	1/201	143/8135	0.9729	0.9948	0.9827	WNT5B	1
KEGG	hsa04010	MAPK signaling pathway	3/201	294/8135	0.9786	0.9948	0.9827	EFNA5/IRAK1/BDNF	3
KEGG	hsa05160	Hepatitis C	1/201	157/8135	0.9811	0.9948	0.9827	CYCS	1
KEGG	hsa03010	Ribosome	1/201	158/8135	0.9815	0.9948	0.9827	RPS29	1
KEGG	hsa04630	JAK-STAT signaling pathway	1/201	162/8135	0.9833	0.9948	0.9827	CREBBP	1
KEGG	hsa04062	Chemokine signaling pathway	1/201	192/8135	0.9923	0.9958	0.9837	ADCY2	1
KEGG	hsa05202	Transcriptional misregulation in cancer	1/201	193/8135	0.9925	0.9958	0.9837	LMO2	1
KEGG	hsa04740	Olfactory transduction	4/201	440/8135	0.9958	0.9958	0.9837	CALM1/CNGB1/OR4D1/OR1D5	4